Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Tissue Heart Valves Market from 2024 to 2025?
The market size for tissue heart valves has seen a stable expansion in the past few years. It is projected to increase from $1.48 billion in 2024 to $1.53 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.1%. The previous growth can be credited to the escalating cases of lifestyle illnesses, augmented spending on healthcare, a rising aging population, an upward trend in cardiac and pathological disorders, and a surge in instances of heart diseases.
What Is the Projected Market Size of the Tissue Heart Valves Market?
Expectations are set for the tissue heart valves market to consistently expand in the coming years, with projections indicating a growth to $1.70 billion by 2029, steered by a Compound Annual Growth Rate (CAGR) of 2.7%. Factors contributing to the predicted growth within the prediction window include the surge in cardiovascular diseases, the increasingly preferred use of sutureless procedures, the sizeable aging populace, augmented demand for cardiovascular therapies, and amplified health sector investments. Key trends anticipated during the prediction period encompass technological novelties, transformative culture systems, progression in imaging technologies, surgical techniques evolution, and the burgeoning of emerging markets.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21302&type=smp
Who are the Major Competitors in the Tissue Heart Valves Market Outlook?
Major companies operating in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomédica, On-X Life Technologies Inc., Anteris Technologies Ltd., Labcor Laboratórios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, Neovasc Inc.
What Is Fueling Growth in the Tissue Heart Valves Market?
The growing occurrence of heart-related conditions is anticipated to fuel the tissue heart valves market. Cardiovascular diseases (CVDs) encompass multiple conditions that impact the heart and blood vessels, including incidents like heart attacks, strokes, and high blood pressure. The surge in CVDs is primarily due to contributors such as unhealthy diets, sedentary lifestyles, aging populations, increased exposure to risk factors, smoking, stress, and urbanization, all escalating the global incidence of heart disorders. Tissue heart valves play a decisive role in combatting CVDs, offering a biocompatible, durable, and less thrombogenic solution for patients needing valve replacements, enhancing long-term cardiac function, and lowering the likelihood of complications. For example, a report published by the Heart Failure Society of America (HFSA) in September 2024 stated that nearly 6.7 million Americans aged 20 and above are currently diagnosed with heart failure (HF). Projections suggest this number will rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. Therefore, the escalating number of CVDs is a major driver for the exponential growth of the tissue heart valve market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21302&type=smp
Which Tissue Heart Valves Market Segments Are Growing the Fastest?
The tissue heart valves market covered in this report is segmented –
1) By Type: Stented Tissue Heart Valves, Stentless Tissue Heart Valves
2) By Valve Type: Aortic, Mitral, Tricuspid, Pulmonary
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Stented Tissue Heart Valves: Bovine Pericardial Valves, Porcine Valves
2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves, Homograft Valves
Which Industry Trends Are Shaping the Future of the Tissue Heart Valves Market?
Leading businesses in the tissue heart valves market are concentrating on creating innovative products like surgical aortic tissue valves. These products aim to simplify the process of implantation and improve the patient’s management over their lifetime. A surgical aortic tissue valve is a prosthetic heart valve created from biological tissue, typically employed in heart surgery to replace an affected or injured aortic valve. For example, in June 2024, Medtronic plc., a company based in Ireland, introduced the Avalus Ultra valve. It is a next-generation surgical aortic tissue valve engineered for ease of implantation and long-term patient management. The Avalus Ultra, with a decade’s worth of clinical experience, boasts of a low valve profile, a polyetheretherketone (PEEK) base frame for maintained circularity, and an industry-leading Effective Orifice Area (EOA) to enhance blood flow. Additionally, the valve now comes with a radiopaque coil that provides clear visibility during future valve-in-valve procedures, ensuring enduring durability for patients suffering from aortic stenosis.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report
Which Countries Are Leading the Tissue Heart Valves Market?
North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21302
This Report Delivers Insight On:
1. How big is the tissue heart valves market, and how is it changing globally?
2. Who are the major companies in the tissue heart valves market, and how are they performing?
3. What are the key opportunities and risks in the tissue heart valves market right now?
4. Which products or customer segments are growing the most in the tissue heart valves market?
5. What factors are helping or slowing down the growth of the tissue heart valves market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model